Cann Group (CAN.AX) Stock Price

Cann Group Price

ASX·CLOSED
0.00AUD+0.0005 (+11.76 %)
Market closed

Revenue has compounded at 57.1% per year over the past 7 years to 13.25 M AUD. Cann Group's net margin stands at -168.7%, up from -579.2% several years earlier. Analysts set a median price target of 1.10 AUD, implying 24,380.0% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 50% above its 52-week low.

Cann Group stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Cann Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cann Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cann Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Cann Group Stock Price History
DateCann Group Price
7/10/20260.00 AUD
7/9/20260.00 AUD
7/8/20260.00 AUD
7/7/20260.00 AUD
7/6/20260.00 AUD
7/3/20260.00 AUD
7/2/20260.00 AUD
7/1/20260.00 AUD
6/30/20260.00 AUD
6/29/20260.00 AUD
6/26/20260.00 AUD
6/25/20260.00 AUD
6/24/20260.00 AUD
6/23/20260.00 AUD
6/22/20260.00 AUD
6/19/20260.00 AUD
6/18/20260.00 AUD
6/17/20260.00 AUD
6/16/20260.00 AUD
6/15/20260.00 AUD
6/12/20260.00 AUD
6/11/20260.00 AUD
6/10/20260.00 AUD
6/9/20260.00 AUD
6/5/20260.00 AUD
6/4/20260.00 AUD
6/3/20260.00 AUD
6/2/20260.00 AUD
6/1/20260.00 AUD
5/29/20260.00 AUD
5/28/20260.00 AUD
5/27/20260.00 AUD
5/26/20260.00 AUD
5/25/20260.00 AUD
5/22/20260.00 AUD
5/21/20260.00 AUD
5/20/20260.00 AUD
5/19/20260.00 AUD
5/18/20260.00 AUD
5/15/20260.00 AUD
5/14/20260.00 AUD
5/13/20260.00 AUD
5/12/20260.00 AUD
5/11/20260.00 AUD
5/8/20260.00 AUD
5/7/20260.00 AUD
5/6/20260.00 AUD
5/5/20260.00 AUD
5/4/20260.00 AUD
5/1/20260.00 AUD
4/30/20260.00 AUD
4/29/20260.01 AUD
4/28/20260.01 AUD
4/27/20260.01 AUD
4/24/20260.01 AUD
4/23/20260.01 AUD
4/22/20260.01 AUD
4/21/20260.00 AUD
4/20/20260.01 AUD
4/17/20260.01 AUD
4/16/20260.01 AUD
4/15/20260.00 AUD
4/14/20260.01 AUD
4/13/20260.01 AUD
4/10/20260.00 AUD
4/9/20260.01 AUD
4/8/20260.00 AUD
4/7/20260.01 AUD
4/2/20260.01 AUD
4/1/20260.01 AUD
3/31/20260.01 AUD
3/30/20260.00 AUD
3/27/20260.00 AUD
3/26/20260.01 AUD
3/25/20260.01 AUD
3/24/20260.01 AUD
3/23/20260.00 AUD
3/20/20260.01 AUD
3/19/20260.01 AUD
3/18/20260.01 AUD
3/17/20260.01 AUD
3/16/20260.01 AUD
3/13/20260.01 AUD
3/12/20260.01 AUD
3/11/20260.01 AUD
3/10/20260.01 AUD
3/9/20260.01 AUD
3/6/20260.01 AUD
3/5/20260.01 AUD
3/4/20260.01 AUD
3/3/20260.01 AUD
3/2/20260.01 AUD
2/27/20260.01 AUD
2/26/20260.01 AUD
2/25/20260.01 AUD
2/24/20260.01 AUD
2/23/20260.01 AUD
2/20/20260.01 AUD
2/19/20260.01 AUD
2/18/20260.01 AUD
2/17/20260.01 AUD
2/16/20260.01 AUD
2/13/20260.01 AUD
2/12/20260.01 AUD
2/11/20260.01 AUD
2/10/20260.01 AUD
2/9/20260.01 AUD
2/6/20260.01 AUD
2/5/20260.01 AUD
2/4/20260.01 AUD
2/3/20260.01 AUD
2/2/20260.01 AUD
1/30/20260.01 AUD
1/29/20260.01 AUD
1/28/20260.01 AUD
1/27/20260.01 AUD
1/23/20260.01 AUD
1/22/20260.01 AUD
1/21/20260.01 AUD
1/20/20260.01 AUD
1/19/20260.01 AUD
1/16/20260.01 AUD
1/15/20260.01 AUD
1/14/20260.01 AUD
1/13/20260.01 AUD
1/12/20260.01 AUD
1/9/20260.01 AUD
1/8/20260.01 AUD
1/7/20260.01 AUD
1/6/20260.01 AUD
1/5/20260.01 AUD
1/2/20260.01 AUD
12/31/20250.01 AUD
12/30/20250.01 AUD
12/29/20250.01 AUD
12/24/20250.01 AUD
12/23/20250.01 AUD
12/22/20250.01 AUD
12/19/20250.01 AUD
12/18/20250.01 AUD
12/17/20250.01 AUD
12/16/20250.01 AUD
12/15/20250.01 AUD
12/12/20250.01 AUD
12/11/20250.01 AUD
12/10/20250.01 AUD
12/9/20250.01 AUD
12/8/20250.01 AUD
12/5/20250.01 AUD
12/4/20250.01 AUD
12/3/20250.01 AUD
12/2/20250.01 AUD
12/1/20250.01 AUD
11/28/20250.01 AUD
11/27/20250.01 AUD
11/26/20250.01 AUD
11/25/20250.01 AUD
11/24/20250.01 AUD
11/21/20250.01 AUD
11/20/20250.01 AUD
11/19/20250.01 AUD
11/18/20250.01 AUD
11/17/20250.01 AUD
11/14/20250.01 AUD
11/13/20250.01 AUD
11/12/20250.01 AUD
11/11/20250.01 AUD
11/10/20250.01 AUD
11/7/20250.01 AUD
11/6/20250.01 AUD
11/5/20250.01 AUD
11/4/20250.01 AUD
11/3/20250.01 AUD
10/31/20250.01 AUD
10/30/20250.01 AUD
10/29/20250.01 AUD
10/28/20250.01 AUD
10/27/20250.01 AUD
10/24/20250.01 AUD
10/23/20250.01 AUD
10/22/20250.01 AUD
10/21/20250.01 AUD
10/20/20250.01 AUD
10/17/20250.01 AUD
10/16/20250.01 AUD
10/15/20250.01 AUD
10/14/20250.01 AUD
10/13/20250.02 AUD
10/10/20250.01 AUD
10/9/20250.01 AUD
10/8/20250.01 AUD
10/7/20250.01 AUD
10/6/20250.01 AUD
10/3/20250.01 AUD
10/2/20250.01 AUD
10/1/20250.01 AUD
9/30/20250.02 AUD
9/29/20250.02 AUD
9/26/20250.02 AUD
9/25/20250.02 AUD
9/24/20250.01 AUD
9/23/20250.01 AUD
9/22/20250.01 AUD
9/19/20250.01 AUD
9/18/20250.01 AUD
9/17/20250.01 AUD
9/16/20250.01 AUD
9/15/20250.01 AUD
9/12/20250.01 AUD
9/11/20250.01 AUD
9/10/20250.01 AUD
9/9/20250.01 AUD
9/8/20250.01 AUD
9/5/20250.01 AUD
9/4/20250.01 AUD
9/3/20250.01 AUD
9/2/20250.01 AUD
9/1/20250.01 AUD
8/29/20250.01 AUD
8/28/20250.01 AUD
8/27/20250.01 AUD
8/26/20250.01 AUD
8/25/20250.01 AUD
8/22/20250.01 AUD
8/21/20250.01 AUD
8/20/20250.01 AUD
8/19/20250.01 AUD
8/18/20250.01 AUD
8/15/20250.01 AUD
8/14/20250.02 AUD
8/13/20250.01 AUD
8/12/20250.01 AUD
8/11/20250.01 AUD
8/8/20250.01 AUD
8/7/20250.01 AUD
8/6/20250.01 AUD
8/5/20250.01 AUD
8/4/20250.01 AUD
8/1/20250.01 AUD
7/31/20250.01 AUD
7/30/20250.01 AUD
7/29/20250.01 AUD
7/28/20250.01 AUD
7/25/20250.01 AUD
7/24/20250.01 AUD
7/23/20250.01 AUD
7/22/20250.01 AUD
7/21/20250.02 AUD
7/18/20250.01 AUD
7/17/20250.01 AUD
7/16/20250.01 AUD
7/15/20250.02 AUD
7/14/20250.02 AUD
Access this data via the Eulerpool API
Get Free API Key

Cann Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
560,000.00 AUD
-5.77 M AUD
-4.73 M AUD
Jan 1, 2019
2.35 M AUD
-11.91 M AUD
-10.93 M AUD
Jan 1, 2020
910,600.00 AUD
-15.44 M AUD
-16.94 M AUD
Jan 1, 2021
4.33 M AUD
-23.46 M AUD
-25.10 M AUD
Jan 1, 2022
6.41 M AUD
-24.55 M AUD
-26.47 M AUD
Jan 1, 2023
13.78 M AUD
-30.63 M AUD
-33.79 M AUD
Jan 1, 2024
17.52 M AUD
-25.35 M AUD
-51.24 M AUD
Jan 1, 2025
13.25 M AUD
-12.51 M AUD
-22.35 M AUD

Cann Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 12, 2026, 10:09 AM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESM
20152016201720182019202020212022202320242025
––––2.00–4.006.0013.0017.0013.00
–––––––50.00116.6730.77-23.53
––––450.00–225.00150.0069.2329.4169.23
9.009.009.002.009.009.009.009.009.005.009.00
–-1.00-2.00-4.00-10.00-16.00-25.00-26.00-33.00-51.00-22.00
––100.00100.00150.0060.0056.254.0026.9254.55-56.86
528.05108.35108.35125.28139.69143.33259.46357.04393.46453.85528.05
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Cann Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cann Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cann Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Cann Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cann Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Cann Group stock margins

The Cann Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cann Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cann Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
410.20 %
-1,029.59 %
-843.91 %
Jan 1, 2019
68.16 %
-507.25 %
-465.40 %
Jan 1, 2020
68.16 %
-1,695.82 %
-1,860.03 %
Jan 1, 2021
68.16 %
-541.21 %
-579.21 %
Jan 1, 2022
68.16 %
-383.00 %
-412.85 %
Jan 1, 2023
68.16 %
-222.31 %
-245.26 %
Jan 1, 2024
30.50 %
-144.67 %
-292.43 %
Jan 1, 2025
68.16 %
-94.41 %
-168.69 %

Cann Group Stock Revenue, EBIT, Earnings per Share

The Cann Group earnings per share therefore indicates how much revenue Cann Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.00 AUD
-0.05 AUD
-0.04 AUD
Jan 1, 2019
0.02 AUD
-0.09 AUD
-0.08 AUD
Jan 1, 2020
0.01 AUD
-0.11 AUD
-0.12 AUD
Jan 1, 2021
0.02 AUD
-0.09 AUD
-0.10 AUD
Jan 1, 2022
0.02 AUD
-0.07 AUD
-0.07 AUD
Jan 1, 2023
0.04 AUD
-0.08 AUD
-0.09 AUD
Jan 1, 2024
0.04 AUD
-0.06 AUD
-0.11 AUD
Jan 1, 2025
0.03 AUD
-0.02 AUD
-0.04 AUD

Cann Group business model & stock analysis

Cann Group Ltd is an Australian company specializing in the production and marketing of medical cannabis. The company was founded in 2013 and is headquartered in Melbourne. The company's history began with the founding of an independent consulting firm called AusCann Group Holdings Ltd in 2014. This firm was created to inform Australian and international investors about the opportunities and possibilities in the Australian cannabis market. In 2016, a cooperation agreement was signed between AusCann and Cann Group Ltd to advance the cultivation and production of medical cannabis products in Australia. Since then, Cann Group has continuously invested in the development and growth of the Australian medical cannabis market. The company has obtained a Good Manufacturing Practices (GMP) compliance license to ensure that all products meet the highest quality and safety standards. This includes collaborating with research institutions and state health authorities to investigate the efficacy and safety of medications. Cann Group's various business areas include the production of medical cannabis, research, product development, and marketing. The company operates a cannabis cultivation facility in Cochranes Hill, Victoria, covering an area of 20 hectares. The cultivation of cannabis is carried out under controlled conditions to ensure that all products are of the highest quality and purity. The cultivated cannabis is then used to manufacture medical products such as oils, tinctures, capsules, and sprays. Cann Group also collaborates closely with research institutions and academic institutions to study the safety and efficacy of medical cannabis. The company has partnerships with the University of Melbourne, Queensland University of Technology, and Swinburne University of Technology for research on the mechanisms of cannabis, application research, and studies on the clinical efficacy of cannabis. The business model of Cann Group is based on the sale of medical cannabis products to pharmacies and medical facilities in Australia and worldwide. The company, through its license, is one of the few companies capable of producing and exporting medical cannabis for the Australian market. In addition to exporting cannabis products to Germany, New Zealand, the UK, and other countries, the sale of cannabis products to the Australian market is the largest market for Cann Group. The company offers a variety of medical cannabis products specifically developed for various medical conditions. These include products for anxiety, nausea and vomiting, pain, seizures, and many other diseases. There are also products for palliative care, which help alleviate pain and suffering in the final stages. Overall, Cann Group Ltd has played a pioneering role in the development of the Australian medical cannabis market in recent years. The company specializes in the production of medical cannabis products that meet the highest quality standards and strict regulatory requirements. The company is committed to improving the therapeutic approach to diseases and enhancing the quality of life for patients.

Cann Group SWOT Analysis

Strengths

  • Strong market position as a leading cannabis producer and supplier
  • Competitive advantage in terms of scale and production capacity
  • Well-established distribution network and customer base
  • Strong brand recognition and reputation in the industry

Weaknesses

  • Reliance on external factors such as government regulations and policies
  • Vulnerability to fluctuations in cannabis prices and demand
  • Potential for increased competition in the market
  • Limited product diversification beyond cannabis-related products

Opportunities

  • Growing acceptance and legalization of cannabis globally
  • Expansion into international markets with relaxed regulations
  • Potential partnerships or collaborations with established pharmaceutical companies
  • Innovation and development of new cannabis-based products

Threats

  • Changing regulatory landscape and potential stricter regulations
  • Risk of product quality and safety concerns affecting consumer trust
  • Economic downturn impacting consumer spending on cannabis products
  • Competition from both existing and new players in the cannabis industry

Cann Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Cann Group historical P/E ratio, EBIT multiple, and P/S ratio

Cann Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Cann Group shares outstanding

The number of shares of Cann Group was 528.05 M in 2025. This indicates how many shares Cann Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
125.28 M Stocks
Jan 1, 2019
139.69 M Stocks
Jan 1, 2020
143.33 M Stocks
Jan 1, 2021
259.46 M Stocks
Jan 1, 2022
357.04 M Stocks
Jan 1, 2023
393.46 M Stocks
Jan 1, 2024
453.85 M Stocks
Jan 1, 2025
528.05 M Stocks

Current Cann Group forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy80.00 % (4)
Hold20.00 % (1)
Sell0.00 % (0)
12M Price Target
1.10
Last Price
0.00
Currency
AUD
12M Return Potential
24,380.00 %
LTM Return
0 %

Cann Group shareholder structure

% Name
2.65127%
Prue (Ryan)
Prue (Ryan)
2.17384%
Jacobsen (Philip)
Jacobsen (Philip)
1.38169%
Mullacam Pty. Ltd.
Mullacam Pty. Ltd.
1.11286%
Flag Capital Pty. Ltd.
Flag Capital Pty. Ltd.
0.99479%
Yang (Jiashun)
Yang (Jiashun)
0.82215%
Supernova Fund Pty. Ltd.
Supernova Fund Pty. Ltd.

Cann Group Executives and Management Board

SD

Mr. Shane Duncan

Chief Operating Officer

Compensation335,627.00 AUD
DR

Mr. Douglas Rathbone

(78)

Interim Non-Executive Chairman of the Board · since 2025

Compensation82,591.00 AUD
JP

Ms. Jenni Pilcher

Chief Executive Officer, Managing Director, Executive Director · since 2020

Compensation77,500.00 AUD
JS

Mr. John Sharman

(57)

Non-Executive Director

Compensation65,000.00 AUD
SN

Mr. Steven Notaro

Company Secretary · since 2024

Frequently asked questions about Cann Group

Cann Group Ltd is an Australian company that operates in the medicinal cannabis industry. Its business model revolves around cultivation, manufacturing, and distribution of pharmaceutical-grade cannabis products and providing services to the medicinal cannabis sector. With a focus on research and development, Cann Group aims to support healthcare professionals and patients by developing high-quality therapeutic products derived from cannabis plants. The company's expertise lies in the production of standardized cannabis cultivars, extraction, and development of new formulations to meet the evolving needs of the medical industry. Cann Group Ltd strives to establish itself as a leading player in the medicinal cannabis market.

All fundamentals and in-depth analysis of Cann Group

Our stock analysis for Cann Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cann Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Cann Group Stock
Cann Group Revenue→
Cann Group Stock
Cann Group Net Income→
Cann Group Stock
Cann Group P/E→
Cann Group Stock
Cann Group P/S→
Cann Group Stock
Cann Group EBIT→
Cann Group Stock
Cann Group Dividend→
Cann Group Stock
Cann Group Directors Dealings→
Cann Group Stock
Cann Group Stocks→
Cann Group Stock
Cann Group Market capitalization→
Cann Group Stock
Cann Group Debt→
Cann Group Stock
Cann Group Liabilities→
Cann Group Stock
Cann Group Equity→
Cann Group Stock
Cann Group AAQS→
Cann Group Stock
Cann Group Employees→
Cann Group Stock
Cann Group ROE→
Cann Group Stock
Cann Group ROA→
Cann Group Stock
Cann Group ROCE→
Cann Group Stock
Cann Group News→
Cann Group Stock
Cann Group Analyst Price Targets→

Health Stocks

Cannabis Global,Candel TherapeuticsCannabis PolandCANbridge PharmaceuticalsCannabist Company HoldingsCanBas CoCannaPharmaRxCanadaBis CapitalCannara BiotechCamurusCannlabsCAMP4 TherapeuticsAll Stocks A–Z →